(Adds details thoroughout) Sept 25 (Reuters) – The US Food and Drug Administration has approved Mirum Pharmaceuticals' drug to treat a rare bone disorder, the regulator said on Friday. The drug,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: MANCHESTER CITY FAN SOLOMON REACTING TO REPORTS OF HIS TEAM BEING FOUND GUILTY…
(Updates with market close) * Akamai Technologies surges on $11.6 billion Anthropic deal * Microsoft…
Sept 25 (Reuters) - A US appeals court on Friday ruled against the prediction markets…
Sept 25 (Reuters) - A US appeals court on Friday ruled against the prediction markets…
(Adds IPO details throughout) Sept 25 (Reuters) - Insurance firm TFP Group, better known as…
VIDEO SHOWS: MANCHESTER CITY FAN SOLOMON REACTING TO REPORTS OF HIS TEAM BEING FOUND GUILTY…